Table 2.
Trends in the NICE scores in the treatment and the no-treatment groupsa.
| No-treatment (n = 41) |
Treatment (n = 43) |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nodule | Infiltration | Cavity | Ectasis | Nodule | Infiltration | Cavity | Ectasis | |||||||||
| Exacerbation | 14 | (31.4) | 18 | (43.9) | 7 | (17.1) | 21 | (51.2) | 9 | (20.9) | 7 | (16.3) | 13 | (30.2) | 15 | (34.9) |
| Fluctuation | 12 | (29.3) | 10 | (24.3) | 4 | (9.8) | 4 | (9.8) | 10 | (23.3) | 15 | (34.8) | 3 | (7.0) | 4 | (9.3) |
| Improvement | 10 | (24.4) | 6 | (14.6) | 2 | (4.9) | 2 | (4.9) | 22 | (51.2) | 16 | (37.2) | 2 | (4.7) | 7 | (16.3) |
| Dormancy | 5 | (12.2) | 7 | (17.1) | 28 | (68.3) | 14 | (3.4) | 2 | (4.7) | 5 | (11.6) | 25 | (58.1) | 17 | (39.5) |
a
The trends in the NICE scores were classified into four categories (exacerbation, fluctuation, improvement, and dormancy) depending on the variation of each regional score during the follow-up period. Data are presented as n (%).